What is the SPYRAL AFFIRM clinical trial?
The main purpose of the SPYRAL AFFIRM study is to evaluate the long-term effects of the Symplicity Spyral system for renal denervation in people with varying severity of hypertension and associated health issues.
The trial is global, however in Oxford the study is being led by Dr Giovanni Luigi De Maria at the John Radcliffe Hospital, Oxford.
What are the eligibility criteria?
To be considered for the trial, you must be between 18 and 80 years of age and have a baseline systolic blood pressure of at least 140 mmHg.
What does the trial involve?
After passing some baseline health checks, if eligible, you will undergo the renal denervation procedure. Your blood pressure and other health markers will then be assessed at 3, 6, 12, 24 and 36 months after this.
You will be required to take your blood pressure at home for at least seven days prior to each post procedure appointment and attend an appointment at the John Radcliffe at the required intervals for hospital blood pressure checks. Blood samples will also be taken at the pre-procedure stage and at 12 months post procedure.
Registration, all procedures, and follow-up appointments are at the John Radcliffe Outpatient Cardiology Clinic, and participation in the trial is free.
How do I sign up?
You will need to be assessed by a cardiologist to determine your suitability and then go through a screening selection process. The first step is to book a hypertension review in the usual way, and then discuss this option with your consultant.
